Beckman Coulter brings the productivity and efficiency benefits of large volume hematology analyzers to small- and medium-sized labs

Rhea-AI Summary

Beckman Coulter announced the launch of the DxH 560 AL, a tabletop analyzer designed for small to mid-sized laboratories. This innovative device features auto-loading functionality, accommodating up to 50 samples and requiring only a 17 μL sample volume, among the lowest in the market. The DxH 560 AL provides results in under 60 seconds, enhancing efficiency. It also includes advanced security features for patient data protection. The analyzer is part of the DxH 500 series, offering high-throughput capabilities while remaining budget-friendly.

Positive

• Launch of the DxH 560 AL analyzer enhances efficiency for small to mid-sized labs.
• Auto-loading functionality allows up to 50 samples, saving time and resources.
• Requires only 17 μL sample volume, making it suitable for difficult-to-draw patients.
• Delivers results in under 60 seconds, improving lab productivity.
• Includes advanced security features for safeguarding patient data.

Negative

• None.

BREA, Calif., Jan. 25, 2021 /PRNewswire/ -- Beckman Coulter, a global leader in clinical diagnostics, announced today the launch of the DxH 560 AL, a tabletop analyzer geared to reduce the time and resource constraints faced by small to mid-sized laboratories. With the analyzer's Auto-Loading functionality, closed tube aspiration and walkaway capabilities, users can continually add up to 50 samples, provide safety against blood-borne pathogens and spend less time on manual instrument tasks. Compactly designed, the DxH 560 AL uses ~30% less counter space than other analyzers in its class.

Smaller labs can now reap the same efficiency and productivity benefits as larger labs without blowing the budget.

The DxH 560 AL delivers results in 60 seconds or less, and is the ideal instrument to use with difficult-to-draw patients (infants, oncology and elderly) as it only needs a 17 μL sample – less than a drop of blood, one of the smallest aspiration volumes on the market. The analyzer also provides industry-leading privacy and security features including customizable user login, paperless data management and fully traceable automated timeouts that guards patient electronic personal health information.

"With proven performance and low-cost to operate, the DxH 560 AL includes the analytical strengths and data management capabilities of high-throughput analyzers in a small footprint," said Peter Soltani, Ph.D., senior vice president and general manager of hematology at Beckman Coulter. "The industry-leading functionality and auto-load capabilities of the DxH 560 AL enables smaller labs to reap the same efficiency and productivity benefits as their larger counterparts without blowing the budget."

The DxH 560 AL is part of Beckman Coulter's DxH 500 series of small footprint tabletop hematology analyzers, including the recently launched DxH 500 and the award winning DxH 520*. The full DxH 500 series of analyzers include dynamic gating for its 5-part differential, eliminating rejected results and lowering manual interventions.

Beckman Coulter's DxH 560 AL builds on the organization's strength in hematology innovation and complements its broad spectrum of hematology analyzers, including the award winning DxH 690T** for mid-volume, DxH 900 for high-volume and DxH connected workcell solutions for ultra-high-volume facilities. For more information on the DxH 560 AL, or the full DxH 500 series, visit https://www.beckmancoulter.com/en/products/hematology.

About Beckman Coulter
Beckman Coulter is committed to advancing healthcare for every person by applying the power of science, technology and the passion and creativity of our teams to enhance the diagnostic laboratory's role in improving healthcare outcomes. Our diagnostic systems are used in complex biomedical testing, and are found in hospitals, reference laboratories and physician office settings around the globe. Beckman Coulter offers a unique combination of people, processes and solutions designed to elevate the performance of clinical laboratories and healthcare networks. We do this by accelerating care with a menu that matters, bringing the benefit of automation to all, delivering greater insights through clinical informatics and unlocking hidden value through performance partnership. An operating company of Danaher Corporation (NYSE: DHR) since 2011, Beckman Coulter is headquartered in Brea, Calif., and has more than 11,000 global associates working diligently to make the world a healthier place.

*Winner of the 2019 SelectScience Scientist's Choice Award for Best News Clinical Instrumentation
**Winner of the 2020 Frost & Sullivan 2020 Global Hematology Testing New Product Innovation Award

© 2021 Beckman Coulter. All rights reserved. Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries.

View original content to download multimedia:http://www.prnewswire.com/news-releases/beckman-coulter-brings-the-productivity-and-efficiency-benefits-of-large-volume-hematology-analyzers-to-small--and-medium-sized-labs-301214191.html

SOURCE Beckman Coulter Diagnostics

FAQ

What is the DxH 560 AL analyzer launched by DHR?

The DxH 560 AL is a tabletop hematology analyzer designed to improve efficiency in small to mid-sized laboratories, allowing for auto-loading of samples and quick result delivery.

How does the DxH 560 AL benefit small laboratories?

It offers large lab efficiency by accommodating up to 50 samples with a low sample volume requirement, helping to save time and costs.

What sample volume is needed for the DxH 560 AL?

The analyzer requires only 17 μL of blood, one of the smallest volumes available in the market.

How quickly does the DxH 560 AL provide results?

It delivers results in less than 60 seconds, significantly enhancing lab productivity.

What features ensure data security in the DxH 560 AL?

It includes customizable user login, paperless data management, and fully traceable automated timeouts to protect patient health information.